BBL
BSX.PRA

Beck Bode LLC’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Beck Bode LLC’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,424
Closed -$245K – 264
2022
Q3 		$245K Buy
2,424
+95
+4% +$9.6K 0.05% 162
2022
Q2 		$236K Buy
+2,329
New +$236K 0.05% 166